D-Wave quantum CHRO Sophie Ames sells $65,548 in shares

D-Wave Quantum CHRO Sophie C. Ames sold 3,070 shares for $65,548 at a weighted average price of $21.3513 under a Rule 10b5-1 plan, leaving her with 643,678 shares, including 639,179 unvested RSUs. The company also reported Q4 2025 revenue of $2.75 million, missing the $3.72 million consensus by 26.1%, with EPS of -$0.09 versus -$0.06 expected. Analyst updates were mixed: Mizuho cut its target to $31 from $40 and Evercore ISI lowered its target to $42 from $44, both maintaining Outperform ratings.

Analysis

The near-term winner is NVDA, not the pure-play quantum names. Even when the sector trades on hype, Nvidia’s ability to define the toolchain and simulation stack gives it a cheaper way to monetize quantum spending than waiting for commercial quantum workloads to scale; that makes the current news flow more meaningful for ecosystem share than for end-demand. By contrast, QBTS is still in the phase where any selloff from insider liquidity is less about governance and more about the market recalibrating the probability of revenue inflection versus dilution, employee monetization, and execution slippage.

The second-order issue for QBTS is that analyst support can hold the stock up tactically, but it does not solve the core problem: the market is paying for an eventually scalable platform while quarterly fundamentals still look like a pre-product company. That mismatch is where drawdowns tend to accelerate once the marginal buyer becomes less willing to underwrite distant TAM. The stock’s prior run makes it especially vulnerable to a sentiment air pocket if the next catalyst is simply another miss or a general rotation out of high-beta AI adjacencies.

IONQ is the cleaner relative long within the group because it has the best chance of becoming the default public-market quantum proxy if investors continue to express the theme. RGTIW looks like the weakest vehicle here: higher optionality but lower liquidity and less ability to absorb bad fundamental prints. The contrarian view is that the current pullback in QBTS may not be large enough if the market starts pricing the sector as a tradeable narrative rather than a funding-cycle story; in that regime, insider selling is not the cause, only the confirmation.

Key Decisions for Investors

• Short QBTS on strength or via a 1-2 month call spread collar: the stock is still priced for narrative continuation, but the next earnings disappointment or sector fade could compress multiple quickly; target a 15-25% downside move versus limited carry cost.
• Long NVDA as the cleaner quantum-enablement beneficiary, 3-6 month horizon: use it as a lower-volatility way to express continued AI/quantum infrastructure capex; risk/reward is better than owning the speculative wrappers.
• Pair trade: long IONQ / short QBTS for 1-3 months: if quantum remains in favor, capital should rotate toward the stronger relative platform story; if the theme cools, QBTS should underperform on higher valuation fragility.
• Avoid initiating fresh longs in RGTIW until liquidity improves: the risk/reward is asymmetric to the downside in any broad de-risking event, and exits can gap through levels.
• If already long QBTS, trim into rallies above recent support and re-enter only after a post-earnings reset or a confirmed contract/cash-flow catalyst; this limits exposure to multiple compression.